Phase I clinical evaluation of bryostatin 1 in combination With 2-CdA [cladribine] in patients wth relapsed CLL [chronic lymphocytic leukaemia]
Phase of Trial: Phase I
Latest Information Update: 13 Jul 2006
At a glance
- Drugs Cladribine (Primary) ; Bryostatin-1
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions
- 06 Sep 2005 New trial record.